The ban on germline editing in humans remains largely in place globally, with most countries prioritizing caution and ethical considerations. However, the rapid pace of technological advancement and the potential for misuse have highlighted the need for stronger international cooperation and oversight. While somatic cell editing continues to advance and show promise for treating diseases, the debate over germline editing is far from settled, with ongoing discussions about its ethical, social, and scientific implications.